Zhang Dan, Wu Jiarui, Wang Kaihuan, Duan Xiaojiao, Liu Shi, Zhang Bing
Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Medicine (Baltimore). 2018 Mar;97(12):e0127. doi: 10.1097/MD.0000000000010127.
The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer.
PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software.
A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences.
As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.
目前,尚无关于何种中药注射剂(CHIs)与XELOX方案联合应用于胃癌患者最为理想的定论。本网状Meta分析(NMA)旨在探究不同CHIs治疗胃癌的最佳选择。
检索PubMed、Embase、Cochrane图书馆、中国知网数据库(CNKI)、万方数据库、维普数据库(VIP)、中国生物医学文献数据库(CBMdisc),以识别聚焦于CHIs治疗胃癌的随机对照试验(RCTs)。采用Cochrane偏倚风险工具对纳入的随机对照试验进行质量评估。通过Stata 13.0和WinBUGS1.4软件进行标准成对和贝叶斯NMA,以比较不同CHIs联合XELOX方案的疗效和安全性。
共检索到2316条记录,证据网络纳入了26项合格的RCTs,涉及13种CHIs和2154例患者。结果表明,与单纯使用XELOX方案相比,参芪扶正+XELOX、华蟾素+XELOX、康艾+XELOX、鸦胆子油乳+XELOX、艾迪注射液+XELOX可能是改善胃癌患者体能状态的最佳治疗方案,其比值比(OR)及95%置信区间(CIs)分别为2.74(1.24,6.17)、8.27(1.74,42.43)、4.28(1.80,10.48)、5.14(1.87,16.28)、0.20(0.090,0.44)。在不良反应(ADRs)方面,复方苦参+XELOX、香菇多糖+XELOX、消癌平注射液+XELOX在减轻白细胞减少方面明显优于单纯接受XELOX方案,其ORs及95% CIs分别为5.62(1.41,36.24)、8.16(2.25,29.4